Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 146,143 | 159,618 | 164,117 | 154,723 | 346,194 |
| Marketable Securities | N/A | N/A | 0 | 8,962 | 11,886 |
| Receivables | 167,424 | 159,242 | 155,296 | 153,125 | 151,208 |
| Inventories | 29,837 | 28,566 | 28,460 | 34,171 | 29,772 |
| Other current assets | 6,614 | 7,417 | 12,606 | 18,741 | 11,892 |
| TOTAL | $373,684 | $376,286 | $382,465 | $392,553 | $573,932 |
| Non-Current Assets | |||||
| PPE Net | 83,659 | 84,834 | 85,470 | 85,462 | 89,603 |
| Intangibles | 802,890 | 810,872 | 818,506 | 825,938 | 854,085 |
| Other Non-Current Assets | 86,298 | 87,838 | 88,339 | 89,997 | 83,810 |
| TOTAL | $972,847 | $983,544 | $992,315 | $1,001,397 | $1,027,498 |
| Total Assets | $1,346,531 | $1,359,830 | $1,374,780 | $1,393,950 | $1,601,430 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 201,131 |
| Accounts payable and accrued liabilities | 25,898 | 23,090 | 22,611 | 27,492 | 16,211 |
| Accrued Expenses | 53,303 | 59,583 | 68,694 | 67,036 | 58,115 |
| Other current liabilities | 561 | 851 | 2,054 | 1,540 | 1,163 |
| TOTAL | $84,590 | $88,300 | $97,866 | $100,120 | $279,695 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 415,731 | 416,749 | 417,778 | 419,814 | 412,496 |
| TOTAL | $433,181 | $434,968 | $438,624 | $439,790 | $433,466 |
| Total Liabilities | $517,771 | $523,268 | $536,490 | $539,910 | $713,161 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 130,212 | 129,812 | 129,388 | 129,179 | 128,695 |
| Common Shares | 129 | 129 | 128 | 128 | 128 |
| Retained earnings | -450,912 | -433,806 | -423,925 | -396,796 | -351,704 |
| Other shareholders' equity | 4 | 4 | 71 | 29 | -56 |
| TOTAL | $828,760 | $836,562 | $838,290 | $854,040 | $888,269 |
| Total Liabilities And Equity | $1,346,531 | $1,359,830 | $1,374,780 | $1,393,950 | $1,601,430 |